financial news - Picoplatin - UPDATE 3-Poniard suspends regulatory efforts on key drug | Reuters

Note: read the whole article "The company said it would focus its resources on developing clinical strategies for picoplatin in small cell lung cancer, as well as colorectal, prostate and ovarian cancers."